Exxon Mobil’s first-quarter earnings missed expectations as the industry came under pressure from eroding refining margins and collapsing natural gas prices.
Schlagwort-Archiv: Markets
Chevron beats earnings estimates but profit falls on lower refining margins and natural gas prices
Chevron produced 1.57 million barrels of oil and gas daily in the U.S. for the quarter, an increase of 35% during the same period last year.
We’re boosting our price target on Alphabet by $30 after it delivered the quarter we’ve been waiting for
Alphabet on Thursday delivered a knockout first-quarter report and joined the tech-industry party by declaring its first-ever dividend.
Microsoft shares jump 4% after the big AI winner delivers in all the right places
Once again, Microsoft touted share gains as more and more customers used Azure’s platforms and tools to build their own AI solutions.
Barclays shares up 4% as bank swings back to profit in first quarter amid strategic overhaul
Barclays on Thursday reported first-quarter net income of £1.55 billion ($1.93 billion), beating expectations and returning the British lender to profit amid a major strategic overhaul.
Nvidia-backed startup Synthesia unveils AI avatars that can convey human emotions
AI startup Synthesia on Thursday announced the launch of its „Expressive Avatars,“ AI-generated digital avatars that can convey human emotions.
Deutsche Bank shares up 7% after first-quarter profit beat, investment banking recovery
Deutsche Bank reported first-quarter earnings on Thursday.
Nvidia supplier SK Hynix reverses losses in first quarter on explosive AI demand
This comes after SK Hynix posted net losses for five consecutive quarters from a slump in the memory chip market.
JPMorgan Chase is caught in U.S-Russia sanctions war after overseas court orders $440 million seized from bank
The escalation shows how American banks are struggling to navigate American sanctions rules more than two years after Russia’s invasion of Ukraine.
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
Bristol Myers Squibb said the charges primarily reflect its acquisition of Karuna Therapeutics and collaboration agreement with SystImmune.